GlobalData on MSN
Artivion treats first subject in trial of Arcevo LSA stent graft
Participants included in the trial have been diagnosed with either aortic dissection or aneurysm involving the aortic arch.
Ja'Cobey James was found guilty of second-degree murder for shooting Joseph Liebe, a total stranger, on Wallace Lake Road in ...
Fort Stockton senior manager and trainer Prestyn Armendariz was never able to play football until he walked in pads for the ...
StockStory.org on MSN
AORT Q3 Deep Dive: AMDS and On-X Outperform, Pipeline and Reimbursement Bolster Outlook
Medical device company Artivion (NYSE:AORT) reported Q3 CY2025 results , with sales up 18.4% year on year to $113.4 million.
19hon MSN
Artivion outlines double-digit revenue growth target for 2025 as AMDS and On-X momentum builds
Discover Artivion's Q3 2025 earnings: double-digit revenue growth, AMDS and On-X momentum, raised outlook, and strategic pipeline progress.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results